Promising Results for Daratumumab in Hard-to-Treat Myeloma Patients - 100303

Spotlight
Video

Promising Results for Daratumumab in Hard-to-Treat Myeloma Patients

ash has 79 videos Subscribe Here

Loading........
Description: Saad Zafar Usmani, MD, shares promising results from the phase II trial of the anti-CD38 monoclonal antibody daratumumab in patients with double refractory heavily pre-treated multiple myeloma.
Shared By : ash
Posted on : 11/05/15
Added : 4 years ago
Category : Multiple Myeloma